secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2026-05-15T20:00:27+00:00
Accession:  0001640334-26-000903
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Artelo Biosciences terminates ATM offering agreement with R.F. Lafferty; minimal prior sales
--------------------------------------------------------------------------------

- Termination notice issued May 11, 2026; effective May 18, 2026.
- Agreement allowed up to $6.5M in common stock sales; only 50,858 shares sold for $451,527 gross proceeds.
- ATM program was entered July 18, 2025 and never significantly utilized.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033426000903/0001640334-26-000903-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033426000903/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-26-000903

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer